Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is… Read more
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) - Net Assets
Latest net assets as of September 2025: $167.11 Million USD
Based on the latest financial reports, Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has net assets worth $167.11 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.69 Billion) and total liabilities ($1.52 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $167.11 Million |
| % of Total Assets | 9.89% |
| Annual Growth Rate | 2.5% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Lumexa Imaging Holdings, Inc. Common Stock - Net Assets Trend (2023–2024)
This chart illustrates how Lumexa Imaging Holdings, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lumexa Imaging Holdings, Inc. Common Stock (2023–2024)
The table below shows the annual net assets of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $203.41 Million | +2.51% |
| 2023-12-31 | $198.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lumexa Imaging Holdings, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9409900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $745.61 Million | 461.24% |
| Total Equity | $161.65 Million | 100.00% |
Lumexa Imaging Holdings, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Lumexa Imaging Holdings, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Roshni Capital Inc.
V:ROSH-P
|
$126.72K |
|
Handelsinvest Danske Obligationer Fund
CO:HAIDKOBL
|
$126.81K |
|
FINLAB N (A7A.SG)
STU:A7A
|
$126.84K |
|
TECHTRONIC IND
MU:TIB1
|
$126.95K |
|
Nuveen California Select Tax Free Income Closed Fund
NYSE:NXC
|
$126.69K |
|
KAWADA TECHNO
BE:0KT
|
$126.68K |
|
SDI Logística Rio - Fundo de Investimento Imobiliário - FII
SA:TRBL11
|
$126.67K |
|
Model Solution Co. Ltd.
KO:417970
|
$126.49K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lumexa Imaging Holdings, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 198,426,000 to 161,654,000, a change of -36,772,000 (-18.5%).
- Net loss of 94,099,000 reduced equity.
- New share issuances of 673,000 increased equity.
- Other factors increased equity by 56,654,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-94.10 Million | -58.21% |
| Share Issuances | $673.00K | +0.42% |
| Other Changes | $56.65 Million | +35.05% |
| Total Change | $- | -18.53% |
Book Value vs Market Value Analysis
This analysis compares Lumexa Imaging Holdings, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.63x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 6.21x to 7.63x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $2.10 | $13.04 | x |
| 2024-12-31 | $1.71 | $13.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lumexa Imaging Holdings, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -58.21%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.92%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 10.59x
- Recent ROE (-58.21%) is above the historical average (-59.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | -61.60% | -13.06% | 0.56x | 8.42x | $-142.07 Million |
| 2024 | -58.21% | -9.92% | 0.55x | 10.59x | $-110.26 Million |
Industry Comparison
This section compares Lumexa Imaging Holdings, Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $167.11 Million | -61.60% | 9.11x | $126.70K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |